Bracco Shapes the Future of Radiology at RSNA 2025

PRINCETON, NJ – Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, will showcase a bold vision for radiology at the Radiological Society of North America (RSNA) 2025 Annual Meeting, to be held November 30 – December 4 in Chicago, Illinois. Guided by its four core pillars—innovation, education, sustainability, and trust—Bracco will highlight its purpose-driven approach and latest advances across imaging modalities. This year’s theme, “Our journey to the future continues today, together, for a sustainable tomorrow,” reflects Bracco’s commitment to partnering with customers and the radiology community to advance patient care while protecting the planet.

Bracco Champions Next-Gen Radiology Education

For more than two decades, Bracco has made education a cornerstone of progress in radiology. In 2024 alone, Bracco’s educational programs reached over 100,000 healthcare professionals worldwide, supported by over 80 active accredited programs and more than $1.4 million in medical education grants.^1,2,3

This year, Bracco will introduce Exploring the Future of MRI Innovation, an immersive and interactive booth learning activity that guides radiologists, technologists, and administrators through a virtual four-room journey spanning the entire Magnetic Resonance Imaging (MRI) experience, beginning in the waiting room and concluding with sustainability. The platform will offer peer-reviewed insights and knowledge checks that simulate real-world decision-making scenarios. As part of Bracco’s commitment to advancing education and environmental responsibility, Bracco will make a corporate donation to independent charitable organizations focused on radiology education and sustainability initiatives. Upon completing the journey, participants will have the opportunity to help determine how Bracco allocates this donation among the selected charitable organizations.

“At RSNA 2025, we’re not just showcasing our vision, we’re inviting the radiology community to step into it,” said Noelle Heber, Executive Director, Radiology Platform, Bracco Americas. “Exploring the Future of MRI Innovation is a hands-on extension of our belief that advancing MR innovation means investing in how we learn, teach, and grow together. It reflects Bracco’s role as a champion of education, a driver of innovation, and a trusted partner in the imaging community.”

Bracco will highlight the expanding role of Contrast-Enhanced Ultrasound (CEUS) in radiology. CEUS offers real-time diagnostic insights without ionizing radiation, making it an increasingly valuable tool. At RSNA 2025, Bracco will underscore CEUS’s importance by convening leading experts to share evolving evidence, best practices, and new frontiers for the technology. In addition to advancing education and innovation, a commitment reinforced by Hexagon, Bracco’s new state-of-the-art Research, Development, and expanded production facility, Bracco is pioneering microbubble technology and accelerating progress in precision imaging.⁴

During RSNA, Bracco will also celebrate the winners of the Leaders on the Horizon Residents’ Program, honoring six residents selected for publication in Applied Radiology.

Driving Innovation Sustainably

Bracco is advancing healthcare innovation while reducing its environmental footprint. Cutting-edge sustainability practices include implementing reverse osmosis and energy efficiency upgrades at manufacturing sites, as well as partnering with customers for responsible stewardship of iodine.¹

A Platinum Medal from EcoVadis in 2025 places Bracco among the top 1% most sustainable companies worldwide. As a member of the United Nations Global Compact, the company upholds high standards of ecological and operational excellence.¹

As part of this commitment, Bracco will host a symposium at RSNA 2025: “The Power of Sustainable Innovation in MRI: Combining AI with Low-Dose GBCA and Rapid-Exchange Contrast Delivery System” on December 1 from 10:30-11:30 AM CST in booth 2387 (South Hall). This one-hour session will feature three leading imaging experts discussing practical strategies for elevating sustainability in the MR suite through advanced contrast delivery, low-dose agents, and AI-powered imaging.

At RSNA 2025, Bracco will highlight its MR portfolio with products designed to reduce waste, lower gadolinium exposure, and lessen environmental impact:

• VUEWAY^® (gadopiclenol) solution for injection, intravenous use, a macrocyclic gadolinium-based contrast agent (GBCA), has achieved 3 million doses.5 VUEWAY injection offers effective contrast enhancement at half the gadolinium (Gd) dose (0.05 mmol/kg) vs. a macrocyclic GBCA at a dose of 0.1 mmol/kg of other similar contrast media for approved indications in the U.S.,6 which can help address the unmet medical need to minimize Gd exposure per MRI procedure, and Gd excretion into the environment, without compromising image quality.^7,8
• Beyond VUEWAY injection, Bracco is proud to offer the Max 3™, a Rapid Exchange and Syringeless MR Injector that is a first of its kind in the MRI space, empowering intuitive, efficient, and easy-to-manage workflow and supporting best practices in radiology sustainability. This injector will strengthen green efforts in radiology suites because it will help contribute less plastic to healthcare facilities' disposable process and costs.¹
• AiMIFY™ Software is the solution for AI-powered contrast enhancement in MR imaging in the U.S. exclusively from Bracco and Subtle Medical. FDA cleared as a class II software medical device; it is intended for image enhancement in brain MRI. AiMIFY software amplifies image contrast enhancement up to two times the level obtained with a labeled dose of a GBCA, significantly improving the visibility of small and large lesions compared to standard post-contrast images.⁹ AiMIFY software can support Neuroradiologists' diagnostic confidence and offers a potentially safer alternative to increasing contrast beyond FDA-approved dosing.⁹ For more information, visit the Bracco booth #1911 and the Subtle Medical booth #4724, South Hall, Level 3.

“At this year’s RSNA, we are proud to highlight how Bracco’s commitment to education and sustainability go hand in hand to drive meaningful progress,” said Cosimo De Pinto, Executive Vice President, Marketing & Commercial Operations, Bracco Americas. “By advancing solutions that reduce environmental impact, we are ensuring that innovation benefits both patients and the planet. Together with our partners, we are shaping a healthier, more sustainable future for radiology.”

Visit Bracco at RSNA in booth #1911, South Hall, Level 3. Follow #BraccoImaging on LinkedIn for the latest updates.